Table 2. Logistic regression models (1–3) predicting fatty liver (FLAll or FLC) with hsa-miR-122-5p or -885-5p and known risk factors and biomarkers of FL.
Outcome | MODEL 1 |
MODEL 2 |
MODEL 3 |
|||
---|---|---|---|---|---|---|
miR-122 | miR-885 | miR-122 | miR-885 | miR-122 | miR-885 | |
NL vs. FLAll | ||||||
n | 703 | 871 | 701 | 868 | 632 | 781 |
p-value | 1.26 * 10−14 | 3.91 * 10−6 | 1.29 * 10−8 | 0.002 | 6.84 * 10−5 | 0.131 |
OR | 2.44 | 1.55 | 2.07 | 1.41 | 1.78 | 1.23 |
95% CI | 1.96–3.09 | 1.29–1.86 | 1.62–2.68 | 1.13–1.77 | 1.35–2.38 | 0.94–1.60 |
NL vs. FLC | ||||||
n | 600 | 752 | 598 | 749 | 545 | 681 |
p-value | 5.59 * 10−9 | 1.33 * 10−4 | 1.93 * 10−6 | 9.83 * 10−4 | 2.48 * 10−3 | 0.353 |
OR | 4.61 | 2.14 | 6.67 | 2.47 | 3.64 | 1.37 |
95% CI | 2.83–7.96 | 1.46–3.19 | 3.28–15.97 | 1.46–4.33 | 1.69–9.29 | 0.71–2.73 |
MODEL 1: *Stepwise logistic regression model predicting FL (either FLAll or FLC) with miR-122-5p or miR-885-5p (one by one forced into model).
MODEL 2: Model 1+ age, sex and BMI.
MODEL 3: Model 2+ alcohol consumption, waist circumference, apolipoprotein B levels, triglycerides, insulin levels, systolic blood pressure, smoking, and physical activity index. This model involves all the explanatory variables that have been previously associated with liver status in Young Finns Study [see ref. 6] excluding liver enzymes due to high correlation with studied miRNAs.
Abbreviations: NL = Normal liver, FL = fatty liver, FLAll = all subjects with fatty liver, FLC = clearly identified fatty liver, miR-122 = hsa-miR-122-5p, miR-885 = hsa-miR-885-5p.